Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation

Transplant Immunology

Volumn 26, Issue 2-3, 2012, Pages 163-170

  Song, Jinghai ^a,b   Hagiya, Hiroshi ^c   Kurata, Haruto ^c   Mizuno, Hirotaka ^c   Ito, Toshinori ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BEIJING HOSPITAL   (China)

^c ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Graft versus host disease (GVHD); Interferon (IFN) ; Rejection; Small bowel transplantation (SBTx); Sphingosine 1 phosphate (S1P) receptor agonist (W 061)

Indexed keywords

FINGOLIMOD PHOSPHATE; FTY 720P; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; W 061;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BODY WEIGHT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; INTESTINE TRANSPLANTATION; LYMPHOCYTE HOMING; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; T LYMPHOCYTE;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYTOKINES; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; PROPYLENE GLYCOLS; RATS; RATS, WISTAR; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856516517     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.12.005     Document Type: Article

References (32)

1. Niv Y., Mor E., Tzakis A.G. Small bowel transplantation: a clinical review. Am J Gastroenterol 1999, 94(11):3126-3130.
2. Schrant W.H. Current status of small bowel transplantation. Gastroenterology 1988, 94(2):525-538.
3. Cai J. Intestine and multivisceral transplantation in the United States: a report of 20-year National Registry Data (1990-2009). Clin Transpl 2009, 83-101.
4. Yanagawa Y., Sugahara K., Kataoka H., Kawaguchi T., Masubuchi Y., Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998, 160(11):5493-5495.
5. Hwang M.W., Matsumori A., Furukawa Y., Ono K., Okada M., Iwasaki A., et al. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation 1999, 100(12):1322-1399.
6. Suzuki S., Enosawa S., Kakefuda T., Shinomiya T., Amari M., Naoe S., et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996, 61(2):200-205.
7. Mizushima T., Ito T., Kishi D., Kai Y., Tamagawa H., Nezu R., et al. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis. Inflamm Bowel Dis 2004, 10(3):182-192.
8. Chiba K., Yanagawa Y., Masubuchi Y., Kataoka H., Kawaguchi T., Ohtsuki M., et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998, 160(11):5037-5044.
9. Luo Z.J., Tanaka T., Kimura F., Miyasaka M. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice. Immunopharmacology 1999, 41(3):199-207.
10. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296(5566):346-349.
11. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277(24):21453-21457.
12. Kimura T., Hasegawa T., Nakai H., Azuma T., Usui N., Sasaki T., et al. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells. Transplantation 2003, 75(9):1469-1474.
13. Song J., Ito T., Matsuda C., Miao G., Tanemura M., Nishida T., et al. Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation. Clin Exp Immunol 2006, 146(1):85-92.
14. Ohno T., Hasegawa C., Nakade S., Kitagawa J., Honda N., Ogawa M. The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling. Biopharm Drug Dispos 2010, 31(7):396-406.
15. Monchik G.J., Russell P.S. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971, 70(5):693-702.
16. Kobayashi E., Kamada N., Enosawa S., Toyama N., Delriviere L., Goto S., et al. Comparison of potentiality to induce graft-versus-host reaction with small bowel, pancreas/spleen, and liver transplantation in the rat. Clin Exp Immunol 1993, 92(3):527-531.
17. Davies M.D., Parrott D.M. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut 1981, 22(6):481-488.
18. Takahashi I., Kiyono H., Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 1997, 112(6):1876-1886.
19. Hashimoto W., Takeda K., Anzai R., Ogasawara K., Sakihara H., Sugiura K., et al. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995, 154(9):4333-4340.
20. Andres A.M., Santamaria M.L., Ramos E., Sarria J., Molina M., Hernandez F., et al. Graft-vs-host disease after small bowel transplantation in children. J Pediatr Surg 2010, 45(2):330-336.
21. Azuma H., Takahara S., Ichimaru N., Wang J.D., Itoh Y., Otsuki Y., et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 2002, 62(5):1410-1419.
22. Ho J.W., Man K., Sun C.K., Lee T.K., Poon R.T., Fan S.T. Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocelular carcinoma. Mol Cancer Ther 2005, 4(9):1430-1438.
23. Pinschewer D.D., Ochsenbein A.F., Odermatt B., Brinkmann V., Hengartner H., Zinkernagel R.M. FTY720 immunosuprression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 2000, 164(11):5761-5770.
24. Shimizu H., Takahashi M., Kaneko T., Murakami T., Hakamata Y., Kudou S., et al. KRP-203, a novel synthetic immuno- suppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation 2005, 111(2):222-229.
25. Fujishiro J., Kudou S., Iwai S., Takahashi M., Hakamata Y., Kinoshita M., et al. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation. Transplantation 2006, 82(6):804-812.
26. Sanna M.G., Liao J., Jo E., Alfonso C., Ahn M.Y., Peterson M.S., et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004, 279(14):13839-13848.
27. Brinkmann V., Cyster J.G., Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004, 4(7):1019-1025.
28. Kellersman R., Zhong R., Kiyochi H., Carcia B., Grant D.R. Reconstruction of the intestinal lymphatic drainage after small bowel transplantation. Transplantation 2000, 69(1):10-16.
29. Imado T., Iwasaki T., Kuroiwa T., Sano H., Hara H. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus- leukemia effect. Transplantation 2004, 77(3):391-398.
30. Snider D., Liang H. Early intestinal Th1 inflammation and mucosal T cell recruitment during acute graft-versus-host reaction. J Immunol 2001, 166(10):5991-5999.
31. Sun D.S., Yagi T., Oyama T., Matsukawa H., Matsuda H., Sadamori H., et al. Intraportal donor bone marrow transplantation improves intestinal allograft survival in rats under fk-506-based immunosuppression. J Int Med Res 2003, 31(4):281-289.
32. McDiarmid S.V., Farmer D.G., Kuniyoshi J.S., Robert M., Khadavi A., Shaked A., et al. The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation. Transplantation 1994, 58(6):690-697.